547OStereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial. (25th November 2018) - Senan, S; Olson, R; Harrow, S; Gaede, S; Louie, A; Haasbeek, C; Mulroy, L; Lock, M; Rodrigues, G; Yaremko, B; Schellenberg, D; Ahmad, B; et al.